Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety and efficacy of mycophenolate mofetil alone,
or with reduced dose cyclosporine (CsA) or tacrolimus, for immunosuppression long-term after
liver transplantation, in an attempt to reduce the potential side effects from using
cyclosporine or tacrolimus.